Price Transparency in Healthcare: What the 2025 Changes Mean for Patients and Providers

Welcome to HealthTech Check Up! Hosts Rachelle Galant and Perry Dimas sit down to chat about one of healthcare’s most complex and long-debated topics: price transparency. From baby steps in shoppable services to the latest White House executive orders and the controversial rollout of a government-run drug pricing website, Rachel and Perry explore what’s driving this new wave of disruption in 2025.

They unpack how these shifts could impact patients, payers, and PBMs, and what it means for innovation in the pharmaceutical industry. Is the U.S. finally closing the gap on international pricing — or just introducing more chaos into an already tangled system?

Tune in for a candid, forward-looking discussion on where price transparency is headed, why it’s proving so difficult to achieve, and how technology might be the bridge to a more equitable and efficient future in healthcare.

💡 Highlights:

• Why price transparency still feels like an uphill battle
  
  
  
• The potential impact of a U.S. “direct-to-consumer” government drug platform
  
  
  
• How employers and PBMs may be forced to adapt
  
  
  
• The role of tech innovation in simplifying healthcare costs
  
  
  
• Can a little chaos lead to long-term progress?
  
  
  

🎧 Listen in as Rachel and Perry break down the complexities — and possibilities — behind healthcare’s newest transformation.

—-------

Keep in touch with our hosts, Rachelle Galant and Perry Dimas on Linkedin!

To learn more about careviso, visit, www.careviso.com